nordihydroguaiaretic acid/neoplasms

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the use of nordihydroguaiaretic acid derivatives, in particular derivatives containing substituents of naturally occuring amino acids, for the treatment of tumors and viral infections. 2. Background

FIELD OF THE INVENTION This invention relates to the use of nordihydroguaiaretic acid derivatives together with 7-hydroxystaurosporine (UCN-01) to treat cancer, prevent metastasis, and prolong the life of a mammal afflicted with a tumor. The invention also relates to methods of using

FIELD OF THE INVENTION This invention relates to the use of nordihydroguaiaretic acid derivatives together with one or more metabolic modulators to treat cancer, prevent metastasis, and prolong the life of a mammal afflicted with a tumor. BACKGROUND Carcinogenesis is a multistage event affected by a

BACKGROUND OF THE INVENTION Carcinogenesis is a multistage event affected by a variety of genetic and epigenetic factors and is typified by the outbreak of uncontrolled cell growth originated from different tissues. A universal goal for anticancer research lies in the development of a clinical

FIELD OF THE INVENTION This invention relates to new methods of treating benign, premalignant and malignant solid tumors, particularly those of the skin, comprising the application to said solid tumors of the herein defined catecholic butanes and pharmaceutical formulations containing said

FIELD OF THE INVENTION This invention relates to new methods of treating benign, premalignant and malignant solid tumors, particularly those of the skin, comprising the application to said solid tumors of the herein defined catecholic butanes and pharmaceutical formulations containing said

BACKGROUND OF THE INVENTION This invention relates to a composition suitable for administration to mammalian hosts as a therapeutic formulation. More particularly, this invention relates to a combination therapy for free-radical bodily damage employing a lymphokine or cytotoxin such as tumor

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the use of nordihydroguaiaretic acid derivatives, in particular derivatives containing substituents of naturally occuring amino acids, for the treatment of tumors and viral infections. 2. Background

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the use of nordihydroguaiaretic acid derivatives, in particular derivatives containing substituents of naturally occuring amino acids, for the treatment of tumors and viral infections. 2. Background

FIELD OF THE INVENTION This invention is in the field of the prevention and treatment of cancer. More specifically, this invention relates to the use of 5-lipoxygenase inhibitors or derivatives thereof in preventing and treating cancer. BACKGROUND OF THE INVENTION Arachidonic acid (AA) is a

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the use of nordihydroguaiaretic acid derivatives, in particular derivatives containing substituents of naturally occuring amino acids, for the treatment of tumors and viral infections. 2. Background

FIELD OF THE INVENTION The invention relates to nordihydroguaiaretic acid derivatives particularly useful for treating viral infections and tumors. BACKGROUND Nordihydroguaiaretic acid (NDGA, 1) is a lignan found in the leaves and twigs of the shrub Larrea tridentata. Being a lipoxygenases

FIELD OF THE INVENTION The invention relates to nordihydroguaiaretic acid derivatives particularly useful for treating viral infections and tumors. BACKGROUND Nordihydroguaiaretic acid (NDGA, 1) is a lignan found in the leaves and twigs of the shrub Larrea tridentata. Being a lipoxygenases

FIELD OF THE INVENTION The present invention relates to chemical compounds that have inhibitory or enhancing effects on cytochrome P450 3A (CYP3A). The preferred inhibitors include free bases or pharmacologically acceptable salts of at least one of the following compounds: nordihydroguaiaretic acid,

BACKGROUND OF THE INVENTION This invention relates to a composition suitable for administration to mammalian hosts as a therapeutic formulation. More particularly, this invention relates to a combination therapy for free-radical bodily damage employing a lymphokine or cytotoxin such as tumor